An Evaluation of New Zealand's Health Research Investment System Based on International Benchmarks

Total Page:16

File Type:pdf, Size:1020Kb

An Evaluation of New Zealand's Health Research Investment System Based on International Benchmarks University of Wollongong Research Online Faculty of Commerce - Papers (Archive) Faculty of Business and Law 1-1-2004 Science for life: an evaluation of New Zealand's health research investment system based on international benchmarks Samuel Garrett-Jones University of Wollongong, [email protected] Tim Turpin University Of Western Sydney Brian Wixted Follow this and additional works at: https://ro.uow.edu.au/commpapers Part of the Business Commons, and the Social and Behavioral Sciences Commons Recommended Citation Garrett-Jones, Samuel; Turpin, Tim; and Wixted, Brian: Science for life: an evaluation of New Zealand's health research investment system based on international benchmarks 2004. https://ro.uow.edu.au/commpapers/846 Research Online is the open access institutional repository for the University of Wollongong. For further information contact the UOW Library: [email protected] Science for life: an evaluation of New Zealand's health research investment system based on international benchmarks Abstract During the past decade there have been major developments in the way that research investments have been monitored and evaluated. While there are differences in the ways governments fund research around the world, and a diversity of approaches to evaluation, there are a number of common themes that can be observed in national experiences. As the importance of evaluation increases, the gap between current practice and best practice becomes more significant, and the need for comparative study and methods development grows. Current international ‘better-practice’ approaches to research evaluation and performance indicators reflect two important considerations. First, they make a clear distinction between input, output and outcome indicators and assessments of impact. Only limited refinements have occurred in recent years in input and output performance indicators. However, quite considerable developments have occurred in relation to the development of indicators and approaches for assessing the outcomes and impact of research.1 Second, evaluation and reporting mechanisms vary considerably according to the intended audience for the reporting. In particular, as nations move toward strategically targeting limited government research resources reporting demands at the programme level, and for specific stakeholder groups becomes all the more pressing. Keywords system, investment, benchmarks, science, health, evaluation, international, research, zealand, life Disciplines Business | Social and Behavioral Sciences Publication Details Garrett-Jones, SE, Turpin, T and Wixted, B, Science for life: an evaluation of New Zealand's health research investment system based on international benchmarks, Wellington, New Zealand: The Ministry of Research Science and Technology, 2004. This report is available at Research Online: https://ro.uow.edu.au/commpapers/846 Science for Life An Evaluation of New Zealand’s Health Research Investment System based on International Benchmarks Final Report Sam Garrett-Jones Tim Turpin Brian Wixted The Australian Expert Group in Industry Studies (AEGIS) AEGIS research focuses on elucidating the dynamics of industrial growth and development, mapping product systems so as to analyse and reveal the drivers of innovation in different industries. AEGIS focuses on exploration and analyses of innovative capacity in industry, including both technological bases and organisational arrangements, and the relationships between such capacity and economic growth. The aim is to provide a more effective basis for public policy development so as to assist with Australia’s shift to the knowledge-intensive economy the nation needs in the twenty- first century. AEGIS has successfully managed numerous consulting research projects for Australian business, Australian Commonwealth and State Government clients, international agencies and foreign national government ministries. AEGIS uses a multi-disciplinary approach, principally sociological and economic but also human geography and management. AEGIS has always operated as a national network of researchers skilled in different aspects of industry analysis but with a small core of researchers in Sydney. AEGIS researchers are currently involved in four major themes. • Industry Innovation • Research systems • Research into Knowledge Intensive Businesses • Econometric Modelling and Forecasting of E-Commerce Diffusion’ The authors of this report are Associate Professor Sam Garrett-Jones, Professor Tim Turpin and Brian Wixted. AEGIS can be contacted at: Level 8, 263 Clarence St Sydney NSW 2000 PO Box Q1287 QVB PO NSW 1230 Phone: (02) 8255 6200 Fax: (02) 8255 6222 Email: [email protected] Web: http://www.aegis.uws.edu.au Science for Life ii ACKNOWLEDGEMENTS We are grateful to Mark Dingle and Cameron Wood of the New Zealand Ministry of Research, Science and Technology for their assistance in helping us with the details of the New Zealand research system, providing us with data and for their comments and suggestions in preparing this report. Staff of the Health Research Council of New Zealand were very helpful in putting us in touch with contacts in health research councils internationally, and with organising a list of high profile medical researchers within the New Zealand system. The presentations by staff on the activities and processes of the HRC and in answering all our queries were also very helpful. In particular we would like to thank Dr Bruce Scoggins and Dr Patricia Anderson for their valuable assistance. We were fortunate to benefit from the experience of a significant number of people from different parts of the research system in New Zealand and to discuss their opinions of the various aspects of the evaluation’s terms of reference. These conversations included staff of the Ministry of Health, the Auckland Hospital, purchase agents and researchers in the universities. Representatives of agencies in Australia, Canada, Ireland, the Netherlands, Sweden, the United Kingdom, and the USA were particularly cooperative in providing published and unpublished data. Susan Cozzens from the School of Public Policy at Georgia Tech pointed us toward the complex array of US data and their limitations and provided helpful comments in interpreting the medical research status of indigenous peoples in Canada and the USA. Finally, we would like to acknowledge the assistance of Celine de Bellis in producing the final report. We are most grateful to all those who have contributed to the development of this report, however, the opinions expressed here are those of the authors and the usual disclaimers apply. Science for Life iii CONTENTS EXECUTIVE SUMMARY ............................................................................................VIII OVERVIEW OF FINDINGS ..................................................................................................VIII RECOMMENDATIONS ..................................................................................................XI AN APPROPRIATE POLICY AND INVESTMENT FRAMEWORK.................................................XI THE FUTURE VISION FOR HEALTH RESEARCH .....................................................................XI THE LEVEL OF INVESTMENT REQUIRED .............................................................................XII 1. INTRODUCTION: HEALTH RESEARCH IN THE 21ST CENTURY................ 13 BACKGROUND .................................................................................................................. 13 Evaluation of Health Research.................................................................................... 13 SCOPE AND TERMS OF REFERENCE .................................................................................... 14 APPROACH TO THE TASKS................................................................................................. 16 NEW ZEALAND IN THE GLOBAL RESEARCH CONTEXT ....................................................... 17 2. NEW ZEALAND’S HEALTH RESEARCH INVESTMENT SYSTEM................. 19 INTRODUCTION ................................................................................................................. 19 RECENT EVOLUTION OF THE RESEARCH INVESTMENT SYSTEM.......................................... 19 THE HEALTH RESEARCH INVESTMENT SYSTEM ................................................................. 21 Non-government funding ............................................................................................. 26 SUMMARY ........................................................................................................................ 26 3. INTERNATIONAL BENCHMARKS I: COMPARATIVE NATIONAL HEALTH RESEARCH INVESTMENT SYSTEMS ....................................................................... 28 CHOICE OF BENCHMARK COUNTRIES ................................................................................ 28 HEALTH RESEARCH INVESTMENT IN AUSTRALIA ............................................................. 28 Policy directions.......................................................................................................... 28 Research priorities and collaboration......................................................................... 31 Indigenous health research ......................................................................................... 33 Infrastructure and overheads ...................................................................................... 33 Commercially Oriented Medical Research ................................................................
Recommended publications
  • Volume 82, No.3, July 2018 ISSN 0110-5566
    ISSN 0110-5566 Volume 82, No.3, July 2018 Trace element partitioning during calcite growth: implications for climate reconstruction studies from New Zealand caves Flavour and aroma analysis by solid-phase microextraction (SPME) and gas chromatography Obituary: Michael Philip Hartshorn FNZIC, FRSNZ Obituary: Kevin Russel Tate FNZIC, FRSNZ Death from the sky: the role of chemistry and chemists in understanding biological extinctions The Periodic Table: revelation by quest rather than by revolution Book review: Mendeleev to Oganesson. A multidisciplinary Perspective on the Periodic Table Some Unremembered Chemists: Francis Brian Shorland Published on behalf of the New Zealand Institute of Chemistry in January, April, July and October. The New Zealand Institute of Chemistry Publisher Incorporated Rebecca Hurrell PO Box 13798 Email: [email protected] Johnsonville Wellington 6440 Advertising Sales Email: [email protected] Email: [email protected] Printed by Graphic Press Editor Dr Catherine Nicholson Disclaimer C/- BRANZ, Private Bag 50 908 The views and opinions expressed in Chemistry in New Zealand are those of the individual authors and are Porirua 5240 not necessarily those of the publisher, the Editorial Phone: 04 238 1329 Board or the New Zealand Institute of Chemistry. Mobile: 027 348 7528 Whilst the publisher has taken every precaution to ensure the total accuracy of material contained in Email: [email protected] Chemistry in New Zealand, no responsibility for errors or omissions will be accepted. Consulting Editor Copyright Emeritus Professor Brian Halton The contents of Chemistry in New Zealand are subject School of Chemical and Physical Sciences to copyright and must not be reproduced in any Victoria University of Wellington form, wholly or in part, without the permission of the PO Box 600, Wellington 6140 Publisher and the Editorial Board.
    [Show full text]
  • Maurice Wilkins Centre
    MAURICE WILKINS CENTRE New Zealand’s Centre of Research Excellence targeting human disease Annual Report 2013 Maurice Wilkins Centre The Maurice Wilkins Centre is New Zealand’s Centre of Research Excellence targeting major human diseases. It focuses on cancer, diabetes and infectious disease. New Zealand has an outstanding reputation for biomedical research. The Centre aims to harness this expertise to develop drugs and vaccines, tools for early diagnosis and prevention, and new models of disease. In addition to translational research that directly targets human disease, the Maurice Wilkins Centre encourages innovative fundamental science that has the potential for high impact on human health. The Maurice Wilkins Centre is a multidisciplinary network that brings together leading biologists, chemists and computer scientists. At the end of 2013 it comprised 148 investigators throughout the country, and over 170 early-career affiliates, linking researchers from six universities, three Crown Research Institutes and two private research institutes. These investigators represent most of New Zealand’s expertise in discovering new drugs, vaccines and diagnostic tools that proceed to clinical trials. As the national hub for molecular biodiscovery the Centre provides a point of contact for a broad range of national scientific expertise. It cultivates collaborations with international researchers and research institutions and also engages with industry and the medical profession. For more information see www.mauricewilkinscentre.org For more information on New Zealand Centres of Research Excellence see www.acore.ac.nz Director’s Report .................................................................................... 2 Contribution to National Goals ............................................................... 4 Research highlights Major award for New Zealand drug inventor ................................. 7 Stepping up the fight: The Tuberculosis Flagship .........................
    [Show full text]
  • Maurice Wilkins Centre
    MAURICE WILKINS CENTRE New Zealand’s Centre of Research Excellence targeting human disease Annual Report 2018 Maurice Wilkins Centre The Maurice Wilkins Centre is New Zealand’s Centre of Research Excellence targeting major human diseases. It focuses on cancer, diabetes and infectious disease. New Zealand has an outstanding reputation for biomedical research. The Centre aims to harness this expertise to develop drugs and vaccines, tools for early diagnosis and prevention, and new models of disease. In addition to translational research that directly targets human disease, the Maurice Wilkins Centre encourages innovative fundamental science that has the potential for high impact on human health. The Maurice Wilkins Centre is a multidisciplinary network that brings together leading biologists, chemists and computer scientists. At the end of 2018 it comprised of 203 investigators throughout the country, over 240 early-career affiliates, and 13 clinical associates, linking researchers and clinicians from six Universities, three Crown Research Institutes, one private research institute and nine district health boards. These investigators represent most of New Zealand’s expertise in discovering new drugs, vaccines and diagnostic tools that proceed to clinical trials. The Centre has also partnered with two Māori organisations to improve the health outcomes of Māori and Pacific peoples. As the national hub for molecular biodiscovery the Centre provides a point of contact for a broad range of national scientific expertise. It cultivates collaborations with international researchers and research institutions and also engages with industry and the medical profession. It is committed to building the economy, and building scale in the New Zealand biomedical sector. For more information see www.mauricewilkinscentre.org For more information on New Zealand Centres of Research Excellence see www.acore.ac.nz 2 Director’s Report ...............................................................................................
    [Show full text]
  • 2011 Academy Annual Report
    This document has been created from historical website content. 2011 Academy Annual Report The 2011 Academy Annual Report details the accomplishments of the Academy of the Royal Society of New Zealand throughout the year. Chair’s foreword As Chair of the Academy Executive Committee since July 2011, I would like to extend my unreserved thanks to Professor Keith Hunter, who preceded me during the first 6 months of 2011, for his effort in guiding the Academy during that time. Thereafter, he supported and advised me in my role as Chair. Also over the last year the Academy Executive Committee members that sit on the Society’s Council, comprising Professor Geoff Austin, Professor Michael Corballis, Professor Keith Hunter, Professor Richard Le Heron, Professor Ken Strongman, Dr Garth Carnaby (Society President) and myself, have worked to enhance the profile of the Academy as the intellectual centre of Royal Society of New Zealand. A significant role of the Chair of the Academy is to chair the annual Fellowship election process. The 2011 round resulted in the selection of 12 new Fellows and one new Honorary Fellow. The Fellowship now stands at 375 and Honorary Fellowship at 57 with representation from 8 countries. This last year has seen considerable discussion within the Academy Executive Committee regarding the size of the Academy and an argument has been put forward that if the Fellowship were to be expanded, then there would be more active Fellows to contribute to the work of the Society. This led to some equivocation and consequently, the 2012 Academy Executive Committee will be undertaking an international comparison regarding the size of the Fellowship.
    [Show full text]
  • Profiling Excellence
    the royal society of new zealand PROFILING EXCELLENCE www.royalsociety.org.nz HIGHLIGHTS FROM 2010 Hu-tia te rito If you were to pluck out o te harakeke, the centre of the fl ax bush, kei hea te ko-mako e ko-? where would the bellbird sing? Kı- mai nei ki ahau. If you were to ask me He aha te mea nui “What is the most important ki te-nei ao? thing in the world?” Ma-ku e kı- atu. I would reply, He tangata, “That it is people, he tangata, people, people.” he tangata. PROFILING EXCELLENCE MESSAGE FROM THE PRESIDENT AND THE CHIEF EXECUTIVE Welcome to Profi ling Excellence for We believe targeted research funding 2010. We are very pleased to present this and scholarships for individuals is vital to publication highlighting the key activities ensure New Zealand’s research in science, of the Royal Society of New Zealand technology and the humanities continues during 2010. to remain internationally competitive and relevant. The stories we have chosen to showcase here provide a snapshot of the broad scope It has also been heartening to see the of our activities. successes of young New Zealanders involved in our student programmes Our theme for the year was ‘knowledge and as they aspire to understand and gain new the mind’, in keeping with 2010 being the knowledge. These students are tomorrow’s fi rst year of the Humanities’ inclusion in our leaders and their enthusiasm is infectious. academy. In particular, we celebrated this It has once again been our privilege through our public lectures, including the to help them on their path to success.
    [Show full text]
  • Profiling Excellence 2011 2 ROYAL SOCIETY of NEW ZEALAND | HIGHLIGHTS of 2011
    Profiling Excellence 2011 2 ROYAL SOCIETY OF NEW ZEALAND | HIGHLIGHTS OF 2011 EXCELLENCE AND KNOWLEDGE 4 6 8 10 12 14 16 18 4 Celebrating excellence Message from the President and the Chief Executive 6 6 Shades of chemistry Welcome to Profiling Excellence, our annual publication which provides a snapshot of the 8 Honouring special Royal Society of New Zealand’s activities during 2011. In this you can read about some of the highlights achievements from our work in the past year – including celebrating the achievements of some of New Zealand’s top 10 Teaching and learning researchers, how we highlighted the International Year of Chemistry, and our involvement in organising New Zealand’s first National Primary Science 12 Supporting researchers Week for schools. As you will see, our work is varied, from our 14 On the world stage extensive lecture programme for the general public, to publishing peer-reviewed research journals, 16 Humanities Aronui to our information papers designed to generate informed debate. 18 New Zealand research We are very fortunate to run a number of contracts which support emerging and established researchers unplugged as they undertake exciting research projects, including through the Rutherford Discovery Fellowships and the prestigious Marsden Fund. Thank you to our many supporters and sponsors who make our work possible and, of course, to our 16 dedicated staff. Dr Garth Carnaby Dr Di McCarthy MNZM FRSNZ ONZM President Chief Executive 4 ROYAL SOCIETY OF NEW ZEALAND | HIGHLIGHTS OF 2011 Celebrating Excellence Every year the Royal Society of New Zealand showcases the contributions made by the country’s top researchers, through medals and awards presented at the annual Research Honours.
    [Show full text]
  • Monday 1 December
    Sunday 30 November Time Event Official opening 5.45 Prof Keith Hunter Arthur Campbell – 75th anniversary of NZIC 8.00 Cocktail function & Opening of Trade Exhibition Monday 1 December Time Event Plenary 9.00-10.00 Professor Max Coleman – Searching for Life on Mars - Phoenix Lander 10.00-10.30 Morning tea – served in the exhibition area Concurrent A – Marine B - Macromolecular C - Plant Biochemistry D – Physical Sessions Biogeochemistry Structure & Function and Molecular Biology Chemistry 10.30-10.50 Kim Currie David Palmer Aluh Nikmatullah Lauri Halonen 10.50-11.10 Andrea de Leon Sigurd Wilbanks Jocelyn Eason 11.10-11.30 Robert Strzepek Warren Tate Phillip West Mikkel Bo Hansen 11.30-11.50 Michael Ellwood Jim Morton Simona Nardozza Anna Garden 11.50-12.10 Sylvia Sander Carla Eaton Daryl Rowan Bun Chan 12.10-12.30 Amir Hamidian Guy Jameson Nick Albert Will Polik 12.30-2.00 Lunch – served in exhibition area Plenary 2.00-3.00 Professor Chris Hunter – Organic and Medicinal Concurrent A – Marine B - Gene Structure & C- Plant Physiology & D – Physical Sessions Biogeochemistry Function Ecophysiology 1 Chemistry 3.00-3.20 David Hutchins Jasna Rakonjac Antonio Ferrante Evan Robertson 3.20-3.40 Doug Mackie Iain Lamont David Whitehead Henrik Kjaergaard 3.40-4.00 Afternoon tea – served in the exhibition area Concurrent A – Marine B - Gene Structure & C- Plant Physiology & D – Physical Sessions Biogeochemistry Function Ecophysiology 1 Chemistry 4.00-4.20 Jill Sutton Chris Brown Nigel Perry Tilo Sohnel 4.20-4.40 Andy Pratt Steven Gieseg Luke Youard
    [Show full text]
  • 2016 Academy Annual Report
    Royal Society of New Zealand | 1 February 2017 2016 ACADEMY ANNUAL REPORT Chair’s Foreword As Chair of the Academy Executive Committee since July 2016, I would like to extend my thanks to Professor Richard Le Heron, who preceded me during the first six months of that year. His efforts in guiding the Academy during that time gave further impetus to the Society’s efforts to enhance the profile of the Academy as the intellectual focus of the Royal Society of New Zealand. Our profile has been further strengthened and supported by the Society’s Council and its wonderful staff. Many new and varied initiatives developed through Society processes continue to re-shape and re- invigorate the Academy while its activities in providing exert advice have garnered wide acclaim and greater international recognition. Membership of the Academy Executive Committee was enlarged to diversify disciplinary perspectives, and to strengthen the Committee’s capacity to address its strategic priorities. This has resulted in the Academy, and indeed the Society, being in arguably the strongest position it has ever been as we move into the celebration of our 150th year in 2017. In 2016 the Society, including the Academy, has made considerable progress advancing its Strategic Plan. Motivated by the aspirational goal of a New Zealand enriched by fostering science, technology and the humanities, four focus areas were identified: relevance; impact; engagement; and excellence. These focus areas not only inform our selection process for Fellowship, but also those topics chosen to advance our expert advice agenda, including our recent “Fact Sheets”. Fellowship issues and the Fellows’ Annual Forum A highlight of the year must be success in our continuing commitment to diversifying the Fellowship.
    [Show full text]